ORBIMED ADVISORS LLC – Celldex Therapeutics, Inc. Transaction History
ORBIMED ADVISORS LLC portfolio value:
$0
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -112.7K shares | -3.03M | $28.11 | 0 |
| Q2 2022 | share | Decrease | -72.25% | -293.4K shares | -10.79M | $26.96 | 112.7K |
| Q1 2022 | share | 0.00% | 0 shares | -1.86M | $34.06 | 406.1K | |
| Q4 2021 | share | Decrease | -1.98% | -8.2K shares | -6.67M | $38.9 | 406.1K |
| Q3 2021 | share | Increase | 0.00% | 414.3K shares | 22.36M | $53.99 | 414.3K |
| Q4 2020 | share | Decrease | -100.00% | -625K shares | -9.26M | $17.52 | 0 |
| Q3 2020 | share | 0.00% | 0 shares | 1.14M | $14.83 | 625K | |
| Q2 2020 | share | Increase | 0.00% | 625K shares | 8.12M | $13 | 625K |